The current study indicates a beneficial survival impact of GLI1, contradicting many previous studies, reporting GLI1 as a potent manipulator in carcinogenesis and as a negative prognostic indicator in breast, gastric, and colorectal cancers [25,26,27]. The gene discussed is GLI1; the disease is colorectal cancer.